Investeringar – LSI Epsilon

AAX Biotech is a research-driven company focused on enabling and accelerating the development of highly effective antibody-based medicines. By offering innovative solutions to well-recognized challenges in the rapidly expanding biotherapeutics market, AAX strive to accelerate drug development and improve therapeutic outcomes.

Key2Brain is a Swedish biotechnology company committed to developing a novel and efficacious brain targeting platform technology. https://www.key2brain.com/

Accurate, accessible and affordable disease diagnostics to improve global health. https://videm.com/

By replacing and reducing traditional animal testing with cutting-edge human cell models, BrainZell are shaping a more sustainable future for medicine. https://brainzell.com/

Atley Solutions is a leading company in Targeted Radionuclide Therapy (TRT): a new and ground-breaking method of treating disseminated cancer with targeted radioactive drugs. https://www.atley.com